Measuring functional SYNTAX score (FSS) in patients with angiographic three-vessel coronary artery disease (3VD) can predict half of patients who would have similar 1-year clinical outcomes whether they underwent percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), according to a subgroup analysis of the FAME 3 trial.